ValuEngine reduces Surgery Partners to ‘sell’ — 3 quick notes

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette.

Advertisement

Here are three quick notes:

1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share.

2. The company’s P/E ratio totals 57.

3. Surgery Partners’ debt-to-equity ratio is 1.56.

More articles on transactions/valuations:
Illinois hospital completes $9.4M outpatient surgery center expansion — 3 insights
Doheny Eye Institute purchases new $50M facility — 5 key notes
Surgery Partners loses up to $9M in Q3 revenue from Hurricanes Harvey, Irma & more: 4 ASC company notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.